June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

'Alarming' rise in diabetes globally by 2050- study

Published 06/22/2023, 06:40 PM
Updated 06/22/2023, 06:46 PM
© Reuters. FILE PHOTO: Insulin supplies are pictured in the Manhattan borough of New York City, New York, U.S., January 18, 2019. REUTERS/Carlo Allegri/File Photo

By Jennifer Rigby

LONDON (Reuters) - Every country in the world will see rates of diabetes rise in the next 30 years without action, according to a new global study.

There are currently 529 million people in the world with diabetes, the study led by researchers at the Institute of Health Metrics and Evaluation at the University of Washington found. They projected that this will more than double to around 1.3 billion people by 2050.

The majority of the cases are type 2 diabetes, the form of the disease that is linked to obesity and largely preventable, the researchers said.

The increase in prevalence globally is not uniform: Some countries and regions are particularly badly hit. For example, prevalence rates are expected to reach 16.8% in North Africa and the Middle East and 11.3% in Latin America and the Caribbean by 2050, compared to an estimated 9.8% globally. Currently, the prevalence is 6.1%. But every country will be impacted, researchers said.

“The rapid rate at which diabetes is growing is not only alarming but also challenging for every health system in the world,” said Liane Ong, lead author of the paper, pointing out that the condition is linked to a number of other heart conditions such as heart disease and stroke.

© Reuters. FILE PHOTO: Insulin supplies are pictured in the Manhattan borough of New York City, New York, U.S., January 18, 2019. REUTERS/Carlo Allegri/File Photo

The growing numbers of people with diabetes is in part driven by rising obesity, and in part by demographic shifts: Prevalence is higher among older adults, the study showed. The data from 204 countries does not take into account the impact of the COVID-19 pandemic because those numbers were not yet available, researchers said.

The study, funded by the Bill and Melinda Gates Foundation, is part of a wider series on diabetes published on Thursday in The Lancet medical journal. The series calls for more effective mitigation strategies and an awareness of inequality, with the majority of diabetes patients living in low- and middle-income countries and unable to access proper treatment.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.